The scavenging of volatile anesthetic agents in the cardiovascular intensive care unit environment: A technical report

Canadian Journal of Anesthesia

Volumn 60, Issue 1, 2013, Pages 38-43

  Pickworth, Thomas ^a   Jerath, Angela ^a,b   Devine, Rita ^a   Kherani, Nazmin ^a   Wąsowicz, Marcin ^a,b  

^a TORONTO GENERAL HOSPITAL   (Canada)

^b UNIVERSITY OF TORONTO   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

INHALATION ANESTHETIC AGENT; ISOFLURANE; SEVOFLURANE;

ANESTHETIC VAPORIZER; ARTICLE; CANADA; CONCENTRATION (PARAMETERS); CONTAMINATION; CORONARY ARTERY BYPASS SURGERY; DRUG SAFETY; ELECTIVE SURGERY; EQUIPMENT DESIGN; HOSPITAL ADMISSION; HUMAN; INFRARED SPECTROPHOTOMETRY; INTENSIVE CARE UNIT; MAJOR CLINICAL STUDY; MINIMUM LUNG ALVEOLUS CONCENTRATION; OUTCOME ASSESSMENT; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); SCAVENGING SYSTEM; SEDATION; SEDATION AGITATION SCALE; STANDARD; VENTILATOR;

EID: 84872598866     PISSN: 0832610X     EISSN: 14968975     Source Type: Journal    
DOI: 10.1007/s12630-012-9814-5     Document Type: Article

References (23)

1. Sackey PV, Martling CR, Granath F, Radell PJ. Prolonged isoflurane sedation of intensive care unit patients with the Anesthetic Conserving Device. Crit Care Med 2004; 32: 2241-6.
2. Sackey PV, Martling CR, Nise G, Radell PJ. Ambient isoflurane pollution and isoflurane consumption during intensive care unit sedation with the Anesthetic Conserving Device. Crit Care Med 2005; 33: 585-90.
3. Mirsattari SM, Sharpe MD, Young GB. Treatment of refractory status epilepticus with inhalational anesthetic agents isoflurane and desflurane. Arch Neurol 2004; 61: 1254-9.
4. Parnass SM, Feld JM, Chamberlin WH, Segil LJ. Status asthmaticus treated with isoflurane and enflurane. Anesth Analg 1987; 66: 193-5.
5. Cascino GD. Generalized convulsive status epilepticus. Mayo Clin Proc 1996; 71: 787-92.
6. Kong KL, Willatts SM, Prys-Roberts C. Isoflurane compared with midazolam for sedation in the intensive care unit. BMJ 1989; 298: 1277-80.
7. Spencer EM, Willatts SM. Isoflurane for prolonged sedation in the intensive care unit; efficacy and safety. Intensive Care Med 1992; 18: 415-21.
8. Meiser A, Sirtl C, Bellgardt M, et al. Desflurane compared with propofol for postoperative sedation in the intensive care unit. Br J Anaesth 2003; 90: 273-80.
9. Ontario Ministry of Labour. Occupational Exposure Limits. Ontario regulation 833/90 amended in 2012 (149/12); Available from URL: http://www.labour.gov.on.ca/english/hs/topics/oels.php (accessed September 2012).
10. Wasowicz M, Jerath A, Djaiani G, et al. Expanding an anesthesiologist role beyond an operating room. Volatile based sedation in cardiac surgical patients. Br J Anesth 2012; 108 (Suppl 2): 1003 (abstract).
11. Wasowicz M, Jerath A, Djaiani G, Sharma V, Luksun W, Katznelson R. Volatile-based sedation. Where is the benefit? Crit Care Med 2011; 39: 237 (abstract).
12. Riker RR, Picard JT, Fraser GL. Prospective evaluation of the Sedation Agitation Scale for adult critically ill patients. Crit Care Med 1999; 27: 1325-9.
13. Doyle DJ, Byrick R, Filipovic D, Cashin F. Silica zeolite scavenging of exhaled isoflurane: a preliminary report. Can J Anesth 2002; 49: 799-804.
14. Janchen J, Bruckner JB, Stach H. Adsorption of desflurane from the scavenging system during high-flow and minimal-flow anaesthesia by zeolites. Eur J Anaesthesiol 1998; 15: 324-9.
15. Rowland AS, Baird DD, Weinberg CR, Shore DL, Shy CM, Wilcox AJ. Reduced fertility among women employed as dental assistants exposed to high levels of nitrous oxide. N Engl J Med 1992; 327: 993-7.
16. Rowland AS, Baird DD, Shore DL, Weinberg CR, Savitz DA, Wilcox AJ. Nitrous oxide and spontaneous abortion in female dental assistants. Am J Epidemiol 1995; 141: 531-8.
17. Knill-Jones RP, Rodrigues LV, Moir DD, Spence AA. Anaesthetic practice and pregnancy: controlled survey of women anaesthetists in the UK. Lancet 1972; 1: 1326-8.
18. Spence AA. Environmental pollution by inhalational anaesthetics. Br J Anaesth 1987; 59: 96-103.
19. McGregor DG. Occupational exposure to trace concentrations of waste anesthetic gases. Mayo Clin Proc 2000; 75: 273-7.
20. Department of Health UK. Health and Safety Commission. List of Approved Workplace Exposure Limits (as consolidated with amendments October 2007). Available from URL: http://www.psi.manchester.ac.uk/aboutus/healthandsafety/ WorkplaceExposureLimits.pdf (accessed October 2012).
21. NIOSH. National Institute for Occupational Safety and Health established recommended exposure limits for the United States, 1992. Available from URL: http://www.osha.gov/dts/osta/anestheticgases/index.html (accessed October 2012).
22. Soukup J, Scharff K, Kubosch K, Pohl C, Bomplitz M, Kompardt J. State of the art: sedation concepts with volatile anesthetics in critically ill patients. J Crit Care 2009; 24: 535-44.
23. Marbini HD, Palayiwa E, Chantler J. Active gas scavenging is unnecessary when using the AnaConDa volatile agent delivery system. Intensive Care Soc 2009; 10: 26-8.